Fe65工程的神经元外体封装corynoxine-B改善认知和阿尔茨海默病的病理学
Ashok Iyaswamy1, Abhimanyu Thakur2,3, Xin-Jie Guan4
1Mr. & Mrs. Ko Chi-Ming Centre for Parkinson's Disease Research, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China. iashok@hkbu.edu.hk.
携带Corynoxine-B的工程外体在阿尔茨海默氏症中向粉样蛋白前体蛋白 (APP) 相互作用.
科学领域:
- 神经科学是一个神经科学.
- 生物技术是生物技术.
- 药理学 药理学是指药理学的学科.
背景情况:
- 阿尔茨海默病 (AD) 涉及海马神经元损伤,粉样质斑块和陶.
- 粉样蛋白前体蛋白 (APP) 细胞内域 (AICD) 结合Fe65蛋白驱动AD的发病.
- 针对APP-Fe65相互作用,为AD提供了一个潜在的治疗策略.
研究的目的:
- 开发一种新的基于外体的针对性药物输送系统,用于阿尔茨海默病.
- 为了设计外体,专门针对大脑中的APP过度表达的神经元.
- 为了研究通过工程外体传递的Corynoxine-B的治疗潜力.
主要方法:
- 工程海马神经元细胞衍生的外体来过度表达Fe65.5.
- 用Corynoxine-B (Cory-B) 装载Fe65工程外体,这是一个自诱导剂.
- 将Fe65-EXO-Cory-B给阿尔茨海默病的小鼠模型.
主要成果:
- Fe65工程外体 (Fe65-EXO) 成功地将Cory-B传递给过度表达APP的神经元.
- Fe65-EXO-Cory-B阻止了Fe65和APP之间的自然相互作用.
- 用Fe65-EXO-Cory-B治疗诱导了AD小鼠的自和改善了认知衰退.
结论:
- Fe65工程外体提供了针对阿尔茨海默氏症治疗的向传递系统.
- 这种方法有效地将Cory-B传递给神经元,诱导自并减轻AD病理.
- Fe65-EXO-Cory-B显示出作为阿尔茨海默病有效治疗干预措施的希望.
更多相关视频
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
相关概念视频
Alzheimer's Disease: Treatment
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Drugs Affecting Neurotransmitter Synthesis
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Amyloid Fibrils
